Open Access
Research note
Issue
Parasite
Volume 19, Number 4, November 2012
Page(s) 441 - 444
DOI https://doi.org/10.1051/parasite/2012194441
Published online 15 November 2012
  1. Ahmadi N. & Dalimi A. Characterization of Echinococcus granulosus isolates from human, sheep and camel in Iran. Infect Genet Evol, 2006, 6 (2), 85–90. [CrossRef] [PubMed] [Google Scholar]
  2. Del Brutto O.H., Rajshekhar V., White A.C. Jr., Tsang V.C., Nash T.E., Takayanagui O.M., Schantz P.M., Evans C.A., Flisser A., Correa D., Botero D., Allan J.C., Sarti E., Gonzalez A.E., Gilman R.H. & Garcia H.H. Proposed diagnostic criteria for neurocysticercosis. Neurology, 2001, 57 (2), 177–183. [CrossRef] [PubMed] [Google Scholar]
  3. Garcia H.H. Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel? Expert Rev Anti Infect Ther, 2008, 6 (3), 295–298. [CrossRef] [PubMed] [Google Scholar]
  4. Garcia H.H., Evans C.A., Nash T.E., Takayanagui O.M., White A.C. Jr., Botero D., Rajshekhar V., Tsang V.C., Schantz P.M., Allan J.C., Flisser A., Correa D., Sarti E., Friedland J.S., Martinez S.M., Gonzalez A.E., Gilman R.H. & Del Brutto O.H. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev, 2002, 15 (4), 747–756. [CrossRef] [PubMed] [Google Scholar]
  5. Garcia H.H., Gonzalez A.E., Evans C.A. & Gilman R.H. Taenia solium cysticercosis. Lancet, 2003, 362 (9383), 547–556. [CrossRef] [PubMed] [Google Scholar]
  6. Gonzalez L.M., Montero E., Harrison L.J., Parkhouse R.M. & Garate T. Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J Clin Microbiol, 2000, 38 (2), 737–744. [PubMed] [Google Scholar]
  7. Gonzalez L.M., Montero E., Puente S., Lopez-Velez R., Hernandez M., Sciutto E., Harrison L.J., Parkhouse R.M. & Garate T. PCR tools for the differential diagnosis of Taenia saginata and Taenia solium taeniasis/cysticercosis from different geographical locations. Diagn Microbiol Infect Dis, 2002, 42 (4), 243–249. [CrossRef] [PubMed] [Google Scholar]
  8. Hawk M.W., Shahlaie K., Kim K.D. & Theis J.H. Neurocysticercosis: a review. Surg Neurol, 2005, 63 (2), 123–132; discussion 132. [CrossRef] [PubMed] [Google Scholar]
  9. Ito A., Takayanagui O.M., Sako Y., Sato M.O., Odashima N.S., Yamasaki H., Nakaya K. & Nakao M. Neurocysticercosis: clinical manifestation, neuroimaging, serology and molecular confirmation of histopathologic specimens. Southeast Asian J Trop Med Public Health, 2006, 37(Suppl. 3), 74–81. [PubMed] [Google Scholar]
  10. Lino-Junior Rde S. Faleiros A.C., Vinaud M.C., Oliveira F.A., Guimaraes J.V., Reis M.A. & Teixeira V.De.P. Anatomopathological aspects of neurocysticercosis in autopsied patients. Arq Neuropsiquiatr, 2007, 65 (1), 87–91. [CrossRef] [PubMed] [Google Scholar]
  11. Montenegro T., Gilman R.H., Castillo R., Tsang V., Brandt J., Guevara A., Sanabria H. Verastegui M., Sterling C. & Miranda E. The diagnostic importance of species specific and cross-reactive components of Taenia solium, Echinococcus granulosus, and Hymenolepis nana. Rev Inst Med Trop Sao Paulo, 1994, 36 (4), 327–334. [CrossRef] [PubMed] [Google Scholar]
  12. Sloan L., Schneider S. & Rosenblatt J. Evaluation of enzymelinked immunoassay for serological diagnosis of cysticercosis. J Clin Microbiol, 1995, 33 (12), 3124–3128. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.